Modern Diagnostic & Research Centre opened higher at ₹57.99, compared with its previous close of ₹55.00. In the last trading session on 12 Nov 2026, the stock traded between ₹57.99 and ₹58.00, with an average traded price of ₹57.99. It showed an upward intraday trend.
An investment of ₹10,000 made 1 year ago in Modern Diagnostic & Research Centre is now worth
₹ 6,106.00
Resulting in a loss of
₹ 3,894.00 (38.94%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+3.00 (+5.45%)
Day High
₹58.00
Day Low
₹57.99
Day Open
₹57.99
Prev Close
₹55.00
Volume
11,200
Value Traded
₹0.06 Cr
1W Return
1.75%
1M Return
-10.33%
3M Return
16.00%
6M Return
-29.53%
1Y Return
-38.94%
Market Cap (₹ Cr.)
88
PE Ratio
-
PB Ratio
1.42
Dividend Yield
-
ROE
8.97%
ROCE
11.22%
Book Value (₹)
38.77
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
1.75%
6 Weeks
-
1 Month
-10.33%
3 Months
16.00%
9 Months
-26.11%
No data available.
Modern Diagnostic & Research Centre submits voting results of 14th AGM
Modern Diagnostic & Research Centre submitted voting results for its 14th AGM held on September 30, 2026. All three ordinary resolutions passed with 100% votes in favour and zero against. Total valid votes cast stood at 11,379,178, representing 75.36% of outstanding shares. Resolutions covered FY26 financial statements adoption, director re-appointment, and auditor re-appointment.
1mo agoModern Diagnostic revenue up 7% in FY26; PAT falls 42% to ₹52.5 crore
Operating income rose 6.6% YoY to ₹8,311.06 lakh in FY26. Profit after tax fell 41.7% to ₹525.33 lakh amid higher expenses. EBITDA margin contracted to 16.18% from 24.00% in FY25. 14th AGM scheduled for September 30, 2026, to approve financials. Company launched five new labs and expanded specialized diagnostics.
2mo agoModern Diagnostic schedules board meeting on Sep 3 to approve AGM notice
Board meeting scheduled for September 3, 2026. Agenda includes AGM notice and Director Report approval. Scrutinizer appointment to be considered. Intimation filed under SEBI LODR Regulation 29.
2mo agoModern Diagnostic FY26 net profit falls 42% to ₹525.33 lakh
Modern Diagnostic and Research Centre Limited reported a 42% decline in net profit to ₹525.33 lakh for FY26, despite a 7% increase in revenue to ₹8,311.06 lakh. Total expenses rose to ₹7,814.58 lakh, impacting profitability. The company utilized ₹1,571.62 lakh of its ₹3,689.28 lakh IPO proceeds for capital expenditure and working capital. Gupta Aiyer & Co issued an unmodified opinion on the audited results.
5mo agoBoard to consider Q4FY26 results on May 29
Modern Diagnostic & Research Centre Limited will hold a board meeting on May 29, 2026, to consider Q4FY26 and FY26 financial results. The meeting will also involve taking the Statutory Auditors' Report on record. The trading window for insiders is closed until 48 hours post-results declaration.
5mo agoPromoters hold 72.85% stake in Modern Diagnostic
Modern Diagnostic & Research Centre Limited disclosed that its promoters hold 72.85% of the company's equity shares, totaling 1,09,99,978 shares. The filing confirms no encumbrance was made on these shares during FY26.
5mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹8,589.00 | +0.87% | ₹1,23,496.64 | 52.40 | +14.55% | |
| ₹946.00 | -0.03% | ₹92,075.15 | 66.60 | -14.28% | |
| ₹685.90 | +1.39% | ₹90,221.72 | 98.20 | +16.25% | |
| ₹720.10 | -2.15% | ₹62,769.13 | 113.80 | +5.69% | |
| ₹763.10 | +0.41% | ₹57,610.86 | 54.00 | -21.28% | |
| ₹1,447.20 | +0.52% | ₹38,911.12 | 63.10 | +23.29% | |
| ₹1,859.10 | +1.03% | ₹37,992.72 | 43.70 | +5.68% | |
| ₹1,981.50 | -1.36% | ₹33,259.24 | 57.30 | +28.64% | |
| ₹729.85 | +0.35% | ₹30,654.17 | 155.10 | +6.18% | |
| ₹446.95 | -0.19% | ₹18,041.99 | 97.10 | -32.67% | |
| ₹554.00 | +0.50% | ₹17,563.25 | 85.10 | +8.39% | |
| ₹670.00 | +0.59% | ₹16,144.77 | 39.00 | +31.68% |
An investment of ₹10,000 made 1 year ago in Modern Diagnostic & Research Centre is now worth
₹ 6,106.00
Resulting in a loss of
₹ 3,894.00 (38.94%)
Note: Past profits do not guarantee future returns.
